Get the Stockscreener App
19.68
1.16%
-0.23
Si Bone Inc stock is traded at $19.68, with a volume of 1.17M.
It is down -1.16% in the last 24 hours and up +6.15% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$19.91
Open:
$19.91
24h Volume:
1.17M
Relative Volume:
1.92
Market Cap:
$882.03M
Revenue:
$206.22M
Net Income/Loss:
$-16.70M
P/E Ratio:
-50.98
EPS:
-0.386
Net Cash Flow:
$-5.55M
1W Performance:
+1.60%
1M Performance:
+6.15%
6M Performance:
+43.96%
1Y Performance:
+30.33%
1-Day Range:
$19.19
$20.02
1-Week Range:
$19.19
$20.26
52-Week Range:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
19.68 | 882.03M | 206.22M | -16.70M | -5.55M | -0.386 |
ABT
Abbott Laboratories
|
104.89 | 181.50B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.75 | 121.20B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.66 | 113.02B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.39 | 64.33B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-26 | Initiated | UBS | Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
Si-Bone director Jeffrey Dunn sells $369,400 in stock By Investing.com - Investing.com Canada
Form 4 Si-Bone Inc For: 11 October By Investing.com - Investing.com South Africa
Si-Bone COO & CFO Anshul Maheshwari sells $94,078 in company stock - Investing.com
Form 4 Si-Bone Inc For: 6 October By Investing.com - Investing.com Nigeria
Si-Bone chief op & financial officer sells $94,078 in stock - Investing.com
Si-Bone SVP Michael Pisetsky sells $56,918 in stock - Investing.com
Tax withholding requires SI-BONE (SIBN) legal chief to sell 3,133 shares - Stock Titan
Si-Bone director Jeffrey Dunn sells $369,400 in SIBN shares By Investing.com - Investing.com Nigeria
Si-Bone director Jeffrey Dunn sells $369,400 in SIBN shares - Investing.com
Form 4 Si-Bone Inc For: 5 October By Investing.com - Investing.com UK
After exercising 20,000 options, SI-BONE (SIBN) director Dunn sold 20,000 shares at an average $18.47. - Stock Titan
SI-BONE Officer Anshul Maheshwari Files Form 144 to Sell 1,731 Shares of Common Stock - Kalkine Media
An officer proposes selling 1,731 SI-BONE (NASDAQ: SIBN) shares valued at $31.3K. - Stock Titan
Tax-related sales accompany a 1,731-share trading-plan sale by SI-BONE (SIBN) CFO - Stock Titan
SI-BONE (SIBN) Climbs 2.08% to $19.15, Pressing Toward Upper Range BoundaryMcClellan Summation - https://www.siam.in/
SI-Bone stock gains after FDA clears spinal fusion system By Investing.com - Investing.com South Africa
SI-BONE receives FDA clearance for spinal fusion system By Investing.com - Investing.com South Africa
SI-BONE receives FDA clearance for spinal fusion system - Investing.com India
SI-Bone stock gains after FDA clears spinal fusion system - Investing.com
OrthoPediatrics Corp. (KIDS) Stock Price, News, Quote & History - ca.finance.yahoo.com
SI-BONE at Morgan Stanley conference: growth broadens beyond pelvis By Investing.com - Investing.com India
SI-BONE (NASDAQ: SIBN) Anticipates Up to $150,000 Charge from iFuse TORQ Packaging Recall - Kalkine Media
Understanding the Setup: (SIBN) and Scalable Risk - Stock Traders Daily
SI-BONE Announces Voluntary Recall of iFuse TORQ Implants - TipRanks
SI-BONE Enters Fourth Amendment To Lease On Sept 11, 2026SEC Filing - TradingView
SIBN stock focus on SI-BONE market and fundamentals - ad-hoc-news.de
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey Dunn sells $378,160 of common stock - Investing.com
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com Canada
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com India
Si-Bone director Jeffrey Dunn sells $378,160 of common stock By Investing.com - Investing.com UK
SI-BONE Director Jeffrey Dunn Announces Stock Option Exercises and Sales Under 10b5-1 Plan - Kalkine Media
SI-BONE (SIBN) director exercises options, sells 20K shares - Stock Titan
SIBN Q2 2026 Earnings: 41% EPS Surprise Lifts Shares HigherEarnings Acceleration Picks - vinanet.vn
SI-BONE stock eases below 19 dollars as investors eye recent growth figures - ad-hoc-news.de
SIBN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 41% EPS Surprise; Stock Declines 1.18% - dars.gov.et
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - The Manila Times
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - Barchart.com
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026 - Yahoo Finance
SI-BONE stock holds its latest gains as investors weigh recent revenue growth - AD HOC NEWS
Si-Bone chief op & financial officer sells $233,970 in stock - Investing.com Australia
Si-Bone chief op & financial officer sells $233,970 in stock - Investing.com Canada
Si-Bone CEO Laura Francis sells $522,595 in company stock - Investing.com India
Si-Bone CEO Laura Francis sells $522,595 in company stock By Investing.com - Investing.com Canada
Si-Bone chief op & financial officer sells $233,970 in stock - Investing.com UK
Si-Bone CEO Laura Francis sells $522,595 in company stock - Investing.com
SI-BONE Inc. (SIBN) Holds Steady at $19.57 as Shares Trade Between Key Support and Resistance LevelsValue Stock Ideas - dars.gov.et
SI-BONE (SIBN) COO & CFO sells 11,636 shares under 10b5-1 plan - Stock Titan
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
SI-BONE officer plans $232K sale of 11,636 shares | SIBN SEC FilingForm 144 - Stock Titan
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Si Bone Inc Stock (SIBN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DAVID & LAURA FRANCIS JOINT RE | Director |
Oct 12 '26 |
Proposed Sale |
19.37 |
38,006 |
736,176 |
0 |
| ANSHUL MAHESHWARI | Officer |
Oct 05 '26 |
Proposed Sale |
18.08 |
1,731 |
31,296 |
0 |
| Maheshwari Anshul | Chief Op & Financial Officer |
Oct 05 '26 |
Sale |
19.50 |
1,731 |
33,754 |
218,235 |
| PISETSKY MICHAEL A. | SVP, Ops & Adm/Chief Legal Ofr |
Oct 02 '26 |
Sale |
18.17 |
3,133 |
56,918 |
270,517 |
| Maheshwari Anshul | Chief Op & Financial Officer |
Oct 02 '26 |
Sale |
18.18 |
3,318 |
60,325 |
219,966 |
| DUNN JEFFREY W | Director |
Oct 01 '26 |
Sale |
18.47 |
20,000 |
369,400 |
16,057 |
| DUNN JEFFREY W | Director |
Oct 01 '26 |
Option Exercise |
4.68 |
20,000 |
93,600 |
36,057 |
| DUNN JEFFREY W | Director |
Sep 01 '26 |
Sale |
18.91 |
20,000 |
378,160 |
16,057 |
| DUNN JEFFREY W | Director |
Sep 01 '26 |
Option Exercise |
4.68 |
20,000 |
93,600 |
36,057 |
| DAVID & LAURA FRANCIS JOINT RE | Director |
Aug 24 '26 |
Proposed Sale |
19.96 |
25,972 |
518,401 |
0 |
7.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):